Pages
Community podiatry - Managing your condition at home
Helpful tips for patients, carers and clinicians to help people with self care
Derbyshire Community Health Services welcomes international nurses
https://dchs.nhs.uk/news/derbyshire-community-health-services-welcomes-international-nurses
Bakewell’s new Newholme Health Centre – latest updates and project plans
https://dchs.nhs.uk/our-services/our-clinicshealth-centres/bakewell-integrated-health-hub
Files
Important Information regarding injectable weight loss medication - Tier 3 Weight Management
Important Information regarding injectable weight loss medication
Disclosure Ref 2025397 - Weight Loss drug.doc
Freedom of information disclosure relating to Wegovy (semaglutide) for weight loss or weight management
Disclosure Ref 2024152 - Waiting times .pdf
Freedom of Information disclosure ref 2024152 relating to number of patients and waiting times for Tier 3 Weight Management Service and access to bariatric surgery
Food Diary NS.pdf
Tier 3 Weight Management Food Diary
Goal Tracker NS.pdf
Tier 3 weight Management Goal Tracker
0458 - Diabetes Referral Form for Management of Diabetes
0458 - Diabetes Referral Form for Management of Diabetes
Risk Management Strategy
DCHS Risk Management Strategy
Coroners Flow Chart on Management of Suspected Confirmed COVID-19 Deceased.pdf
DCHS Coroners flowchart on the management of suspected and confirmed Covid-19 cases
The Management of Warfarin Therapy for Inpatients Guidelines (G233)
The aim of this guideline is to improve the safety of anticoagulant therapy for inpatients under the care of DCHS by: • Providing an evidence-based algorithm for the initiation of warfarin therapy in atrial fibrillation, including the use of a specific SystmOne template for warfarin management. • Offering an evidence-based algorithm to guide maintenance dosing decisions. • Clarifying the process for communicating follow-up arrangements to primary care teams when a patient is discharged from hospital. • Endorsing the level of competence and training required of clinicians who prescribe warfarin. • Ensuring that the guidance will be built into an audit and review cycle.
Disclosure Ref 2022120 - Complaints from patients regarding being obese or overweight.pdf
Complaints from patients regarding being obese or overweight